Edition:
United Kingdom

Biofrontera AG (BFRA.OQ)

BFRA.OQ on NASDAQ Stock Exchange Capital Market

13.30USD
17 Oct 2018
Change (% chg)

-- (--)
Prev Close
$13.30
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
1,382
52-wk High
$17.87
52-wk Low
$11.25

Chart for

About

Biofrontera AG is a Germany-based biopharmaceutical company. The Company develops drugs and medicinal cosmetics for the treatment of skin diseases and regenerative care of damaged skin. Its portfolio includes: Ameluz, for photodynamic therapy (PDT) of actinic keratoses, and under development for other types of skin cancer and... (more)

Overall

Beta: -0.01
Market Cap(Mil.): €139.64
Shares Outstanding(Mil.): 38.42
Dividend: --
Yield (%): --

Financials

  BFRA.OQ Industry Sector
P/E (TTM): -- 30.90 33.64
EPS (TTM): -0.46 -- --
ROI: -184.45 14.75 14.27
ROE: -276.38 16.24 15.99

BRIEF-Biofrontera Comments On Tender Offer By Deutsche Balaton

* Said on Thursday Comments On Tender Offer By Deutsche Balaton

03 Aug 2018

BRIEF-Deutsche Balaton Biotech: Alternative Consideration To Offer For Biofrontera Shares

* SAID ON FRIDAY WITHIN THE OFFER FOR BIOFRONTERA SHARES, A WARRANT IS LISTED ON THE OPEN MARKET OF THE HANSEATIC STOCK EXCHANGE HAMBURG ON JULY 20, 2018 WITH 5.04 EUROS

23 Jul 2018

Earnings vs. Estimates